Author Question: A patient with a diagnosis of lung cancer has recently developed metastases to the bone which is ... (Read 18 times)

Mr. Wonderful

  • Hero Member
  • *****
  • Posts: 866
A patient with a diagnosis of lung cancer has recently developed metastases to the bone which is causing severe pain. The nurse would characterize this patient's pain as being which type?
 
  A) Chronic
  B) Neuropathic
  C) Somatic nociceptive
  D) Visceral nociceptive

Question 2

A patient, age 28, has sought medical attention because her hands and feet have become enlarged. She also has noticed amenorrhea and increased hair growth. These symptoms most likely indicate problems with the
 
  a. pituitary gland.
  b. adrenal glands.
  c. thyroid gland.
  d. pancreas.



amandanbreshears

  • Sr. Member
  • ****
  • Posts: 320
Answer to Question 1

C
Feedback:
Pain that originates from the bones is classified as somatic nociceptive. Chronic pain has been present for 3 months or longer. Neuropathic pain occurs from abnormal processing of sensory stimuli. Visceral pain is another term for referred pain and is deep and aching.

Answer to Question 2

A
The pituitary gland may produce an overabundance of growth hormone. This overproduction of hormones may cause changes throughout the patient's body, including enlargement of the pituitary gland and hands and feet. Female patients may develop a deepened voice, increased facial hair growth, and amenorrhea.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

On average, someone in the United States has a stroke about every 40 seconds. This is about 795,000 people per year.

Did you know?

Stroke kills people from all ethnic backgrounds, but the people at highest risk for fatal strokes are: black men, black women, Asian men, white men, and white women.

Did you know?

There are 60,000 miles of blood vessels in every adult human.

Did you know?

You should not take more than 1,000 mg of vitamin E per day. Doses above this amount increase the risk of bleeding problems that can lead to a stroke.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library